The expression of LINC-PINT was approximately 2.85-fold lower in tumor tissues (n = 90) than in the control group (n = 7), which was consistent with the analysis of NPC cell lines. The gene discussed is LINC-PINT; the disease is nasopharyngeal carcinoma.